Published in Sci Transl Med on May 27, 2015
Glia as drivers of abnormal neuronal activity. Nat Neurosci (2015) 0.99
Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema. Oncotarget (2016) 0.88
The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc(-). Cancer Res (2016) 0.86
Seizures and gliomas - towards a single therapeutic approach. Nat Rev Neurol (2016) 0.83
Pilot Preclinical and Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-Glutamate (18F-FSPG) for PET/CT Imaging of Intracranial Malignancies. PLoS One (2016) 0.79
Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy. Neuro Oncol (2015) 0.79
Temozolomide toxicity operates in a xCT/SLC7a11 dependent manner and is fostered by ferroptosis. Oncotarget (2016) 0.78
Progressive neuronal activation accompanies epileptogenesis caused by hippocampal glutamine synthetase inhibition. Exp Neurol (2016) 0.75
Excitotoxic SLC7A11 Expression Is a Marker of Poor Glioblastoma Survival and a Potential Therapeutic Target. Neurosurgery (2015) 0.75
Long-range and short-range tumor-stroma networks synergistically contribute to tumor-associated epilepsy. Oncotarget (2016) 0.75
Glioma, glutamate (SLC7A11) and seizures-a commentary. Ann Transl Med (2017) 0.75
Highlights from the Literature. Neuro Oncol (2015) 0.75
The role of glutamate transport and SLC7A11 expression in tumor-associate seizures and survival in patients with malignant gliomas. Ann Transl Med (2016) 0.75
mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT. Mol Cell (2017) 0.75
ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner. Oncogene (2017) 0.75
Development of a primary microglia screening assay and its use to characterize inhibition of system xc(-) by erastin and its analogs. Biochem Biophys Rep (2017) 0.75
Improved method for accurate and efficient quantification of MRS data with use of prior knowledge J Magn Reson (1997) 6.84
Java-based graphical user interface for the MRUI quantitation package. MAGMA (2001) 5.78
Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme. Neuro Oncol (2005) 4.10
Glutamate release promotes growth of malignant gliomas. Nat Med (2001) 3.67
Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience (1985) 3.53
Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem (1984) 3.39
Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR. Genes Chromosomes Cancer (2004) 3.05
Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J Biol Chem (1999) 2.96
Blockage of Ca(2+)-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells. Nat Med (2002) 2.61
Glioma cells release excitotoxic concentrations of glutamate. Cancer Res (1999) 2.34
Inhibition of cystine uptake disrupts the growth of primary brain tumors. J Neurosci (2005) 2.17
Exchange of cystine and glutamate across plasma membrane of human fibroblasts. J Biol Chem (1986) 2.11
Autocrine glutamate signaling promotes glioma cell invasion. Cancer Res (2007) 2.03
Glutamate release by primary brain tumors induces epileptic activity. Nat Med (2011) 2.00
Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange. J Neurosci (1999) 1.94
Excitotoxicity and stroke: identifying novel targets for neuroprotection. Prog Neurobiol (2013) 1.87
Glutamate is associated with a higher risk of seizures in patients with gliomas. Neurology (2012) 1.69
Small interfering RNA-mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema. Nat Med (2008) 1.66
Membrane potential bistability is controlled by the hyperpolarization-activated current I(H) in rat cerebellar Purkinje neurons in vitro. J Physiol (2002) 1.54
In vivo assessment of high-grade glioma biochemistry using microdialysis: a study of energy-related molecules, growth factors and cytokines. J Neurooncol (2009) 1.50
Glutamate and the biology of gliomas. Glia (2010) 1.48
Ca2+-permeable AMPA receptors regulate growth of human glioblastoma via Akt activation. J Neurosci (2007) 1.35
Assessments of function and biochemistry of the anterior cingulate cortex in schizophrenia. Biol Psychiatry (2010) 1.33
Expression of the cystine-glutamate exchanger (xc-) in retinal ganglion cells and regulation by nitric oxide and oxidative stress. Cell Tissue Res (2006) 1.32
Efficacy of anti-epileptic drugs in patients with gliomas and seizures. J Neurol (2009) 1.26
Excitotoxic mechanisms of epileptic brain damage. Adv Neurol (1986) 1.24
NHERF-1: modulator of glioblastoma cell migration and invasion. Neoplasia (2009) 1.22
AMPA receptors promote perivascular glioma invasion via beta1 integrin-dependent adhesion to the extracellular matrix. Neuro Oncol (2008) 1.18
Characterization of oligodendrogliomas using short echo time 1H MR spectroscopic imaging. NMR Biomed (2003) 1.18
Fluorescence measurement of changes in intracellular calcium induced by excitatory amino acids in cultured cortical astrocytes. J Neurosci (1990) 1.16
Selective vulnerability of the brain: new insights into the pathophysiology of stroke. Ann Intern Med (1989) 1.14
Mitochondrial hyperpolarization after transient oxygen-glucose deprivation and subsequent apoptosis in cultured rat hippocampal neurons. Brain Res (2003) 1.14
Seizure characteristics and prognostic factors of gliomas. Epilepsia (2013) 1.13
Long-term seizure outcomes in adult patients undergoing primary resection of malignant brain astrocytomas. Clinical article. J Neurosurg (2009) 1.11
Role of glutathione in cancer pathophysiology and therapeutic interventions. J Exp Ther Oncol (2012) 1.04
Increased xCT expression correlates with tumor invasion and outcome in patients with glioblastomas. Neurosurgery (2013) 1.04
Expression patterns of glial fibrillary acidic protein (GFAP)-delta in epilepsy-associated lesional pathologies. Neuropathol Appl Neurobiol (2009) 1.03
Bradykinin-induced chemotaxis of human gliomas requires the activation of KCa3.1 and ClC-3. J Neurosci (2013) 1.03
Seizure prognosis in brain tumors: new insights and evidence-based management. Oncologist (2014) 0.98
Reaction of oligodendrocytes and astrocytes to trauma and implantation. A combined autoradiographic and immunohistochemical study. Lab Invest (1985) 0.98
Correlation between genetic alterations and growth of human malignant glioma xenografted in nude mice. Br J Cancer (2003) 0.97
Hypoxia increases the dependence of glioma cells on glutathione. J Biol Chem (2010) 0.97
Pharmacotherapy of epileptic seizures in glioma patients: who, when, why and how long? Onkologie (2005) 0.96
Seizures following intracranial surgery: incidence in the first post-operative week. Can J Neurol Sci (1980) 0.94
Regulation of the system x(C)- cystine/glutamate exchanger by intracellular glutathione levels in rat astrocyte primary cultures. Glia (2011) 0.93
Bursting-induced epileptiform EPSPs in slices of piriform cortex are generated by deep cells. J Neurosci (1991) 0.92
Kinase activation of ClC-3 accelerates cytoplasmic condensation during mitotic cell rounding. Am J Physiol Cell Physiol (2011) 0.92
Inhibition of xc⁻ transporter-mediated cystine uptake by sulfasalazine analogs. Bioorg Med Chem Lett (2011) 0.92
The mTOR pathway is activated in glial cells in mesial temporal sclerosis. Epilepsia (2012) 0.90
Regulation of astrocyte glutamine synthetase in epilepsy. Neurochem Int (2013) 0.90
The Alzheimer's amyloid precursor protein is produced by type I astrocytes in primary cultures of rat neuroglia. J Neurosci Res (1990) 0.89
Bursting induces persistent all-or-none EPSPs by an NMDA-dependent process in piriform cortex. J Neurosci (1989) 0.89
Elevated plasma S100B concentration is associated with mesial temporal lobe epilepsy in Han Chinese: a case-control study. Neurosci Lett (2010) 0.87
Role of GFAP in CNS injuries. Neurosci Lett (2014) 0.86
Role of glutamate transporters in redox homeostasis of the brain. Neurochem Int (2014) 0.86
Delayed post-conditioning reduces post-ischemic glutamate level and improves protein synthesis in brain. Neurochem Int (2013) 0.79
Decreased expression of the active subunit of the cystine/glutamate antiporter xCT is associated with loss of heterozygosity of 1p in oligodendroglial tumours WHO grade II. Histopathology (2009) 0.79
Novel di-aryl-substituted isoxazoles act as noncompetitive inhibitors of the system Xc(-) cystine/glutamate exchanger. Neurochem Int (2013) 0.78
A review of the use of antiepileptic drugs in high-grade central nervous system tumors. Am J Hosp Palliat Care (2012) 0.78